MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

MedAlliance-SELUTION

More Like This

PR Newswire associated0

MedAlliance Acquired by Cordis for up to USD 1.135 Billion

Reflow Medical Enrolls First Patients in Pilot Study of Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute)

PR Newswire associated0

CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US

PR Newswire associated0

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition

PR Newswire associated0

Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry

MERIL Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT, Presented at EuroPCR 2024 - Earns Prestigious Late Breaking Trial Status & The LANCET Acceptance

PR Newswire associated0

Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®

PR Newswire associated0

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023